120 related articles for article (PubMed ID: 20661198)
1. Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass.
Choi YS; Shim JK; Hong SW; Kim JC; Kwak YL
Minerva Anestesiol; 2010 Aug; 76(8):584-91. PubMed ID: 20661198
[TBL] [Abstract][Full Text] [Related]
2. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
[TBL] [Abstract][Full Text] [Related]
3. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.
Boldt J; Suttner S; Brosch C; Lehmann A; Röhm K; Mengistu A
Anesth Analg; 2009 Dec; 109(6):1752-62. PubMed ID: 19923501
[TBL] [Abstract][Full Text] [Related]
4. Profound effects of cardiopulmonary bypass priming solutions on the fibrin part of clot formation: an ex vivo evaluation using rotation thromboelastometry.
Brinkman AC; Romijn JW; van Barneveld LJ; Greuters S; Veerhoek D; Vonk AB; Boer C
J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):422-6. PubMed ID: 20056447
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyethyl starch in priming fluid for cardiopulmonary bypass.
Sade RM; Crawford FA; Dearing JP; Stroud M
J Thorac Cardiovasc Surg; 1982 Jul; 84(1):35-8. PubMed ID: 6177973
[TBL] [Abstract][Full Text] [Related]
6. The safety and efficacy of ten percent pentastarch as a cardiopulmonary bypass priming solution. A randomized clinical trial.
London MJ; Franks M; Verrier ED; Merrick SH; Levin J; Mangano DT
J Thorac Cardiovasc Surg; 1992 Aug; 104(2):284-96. PubMed ID: 1379660
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass.
Sade RM; Stroud MR; Crawford FA; Kratz JM; Dearing JP; Bartles DM
J Thorac Cardiovasc Surg; 1985 May; 89(5):713-22. PubMed ID: 2581099
[TBL] [Abstract][Full Text] [Related]
8. Comparison of low molecular weight hydroxyethyl starch and human albumin as priming solutions in children undergoing cardiac surgery.
Miao N; Yang J; Du Z; Liu W; Ni H; Xing J; Yang X; Xu B; Hou X
Perfusion; 2014 Sep; 29(5):462-8. PubMed ID: 24658707
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effects of 6% and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients.
Friedman G; Jankowski S; Shahla M; Gomez J; Vincent JL
J Clin Anesth; 2008 Nov; 20(7):528-33. PubMed ID: 19019650
[TBL] [Abstract][Full Text] [Related]
10. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial.
Chong Sung K; Kum Suk P; Mi Ja Y; Kyoung Ok K
Acta Anaesthesiol Scand; 2006 Jan; 50(1):108-11. PubMed ID: 16451158
[TBL] [Abstract][Full Text] [Related]
11. Isovolemic hemodilution alters the ratio of whole-body to large-vessel hematocrit (F-cell ratio). A prospective, randomized study comparing the volume effects of hydroxyethyl starch 200,000/0.62 and albumin.
Haller M; Brechtelsbauer H; Akbulut C; Fett W; Briegel J; Finsterer U
Infusionsther Transfusionsmed; 1995 Apr; 22(2):74-80. PubMed ID: 7540445
[TBL] [Abstract][Full Text] [Related]
12. Hemostatic effects of three colloid plasma substitutes for priming solution in cardiopulmonary bypass.
Tigchelaar I; Gallandat Huet RC; Korsten J; Boonstra PW; van Oeveren W
Eur J Cardiothorac Surg; 1997 Apr; 11(4):626-32. PubMed ID: 9151028
[TBL] [Abstract][Full Text] [Related]
13. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery?
Ooi JS; Ramzisham AR; Zamrin MD
Asian Cardiovasc Thorac Ann; 2009 Aug; 17(4):368-72. PubMed ID: 19713332
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a waxy maize and a potato starch-based balanced hydroxyethyl starch for priming in patients undergoing coronary artery bypass grafting.
Sethi BS; Chauhan S; Bisoi AK; Kapoor PM; Kiran U; Rajput RS
J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):690-7. PubMed ID: 24144628
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG.
Vanhoonacker J; Ongenae M; Vanoverschelde H; Donadoni R
Acta Anaesthesiol Belg; 2009; 60(2):91-7. PubMed ID: 19594090
[TBL] [Abstract][Full Text] [Related]
16. Fluid management in cardiac surgery: is one hydroxyethyl starch solution safer than another?
Haynes GR
J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):916-7. PubMed ID: 17138110
[No Abstract] [Full Text] [Related]
17. [Coagulation changes during aortofemoral bifurcation bypass: is volume and plasma substitution possible with hydroxyethyl starch alone?].
von Sommoggy S; Fraunhofer J; Jelen-Esselborn S; Stemberger A
Anaesthesist; 1990 Jul; 39(7):353-60. PubMed ID: 1696795
[TBL] [Abstract][Full Text] [Related]
18. The impact of balanced hydroxylethyl starch cardiopulmonary bypass priming solution on the fibrin part of clot formation: ex vivo rotation thromboelastometry.
Appelman MH; van Barneveld LJ; Romijn JW; Vonk AB; Boer C
Perfusion; 2011 May; 26(3):175-80. PubMed ID: 21177722
[TBL] [Abstract][Full Text] [Related]
19. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials.
Navickis RJ; Haynes GR; Wilkes MM
J Thorac Cardiovasc Surg; 2012 Jul; 144(1):223-30. PubMed ID: 22578894
[TBL] [Abstract][Full Text] [Related]
20. [Open heart surgery without homologous blood transfusion for tetralogy of Fallot--use of hydroxyethyl starch diminishes the necessity of protein transfusion].
Takahashi Y; Tatsuno K; Kikuchi T; Suzuki Y; Kasahara K; Furusawa T; Okada Y
Nihon Kyobu Geka Gakkai Zasshi; 1997 May; 45(5):694-9. PubMed ID: 9170860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
